What is Cullinan Therapeutics, Inc.'s net margin?

Cullinan Therapeutics, Inc. (CGEM) reported net margin of -346.1% in Q4 2021.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Cullinan Therapeutics, Inc. CGEM Net margin

Discontinued — last reported Q4 '21

Net margin at other companies

Eli LillyLLY

35%+12.3pp

Johnson & JohnsonJNJ

21.8%-2.6pp

AmgenAMGN

21%+3.6pp

Regeneron PharmaceuticalsREGN

29.6%-2.3pp

Janux TherapeuticsJANX

-833.6%+0.9pp

Nektar TherapeuticsNKTR

-284.2%+937pp

Other financials

Income statement

See full

Revenue-—

Operating income-$53.7M+2.4%

Net income-$49.7M-2.4%

EPS (diluted)-$0.69+24.2%

Balance sheet

See full

Cash & equivalents$75.1M-2.1%

Total debt$2.4M+29.5%

Total equity$408.7M-30.8%

Total assets$403.0M-30.5%

Cash flow

See full

Operating cash flow-$46.0M-6.7%

CapEx$11.0K—

Free cash flow-$38.1M-4.1%

Valuation

See full

Market cap$1.08B+140%

Enterprise value$1.01B+168%

Profitability

See full

Operating margin-358.7%—

Returns & leverage

See full

Return on equity-44%+26.2pp

Debt / equity0×0.0×

Current ratio10.3×-1.3×

Where this comes from

Calculated from Cullinan Therapeutics, Inc.’s reported figures.

net income/total revenue=-346.1%

Based on trailing twelve months.

The official record: Cullinan Therapeutics, Inc.’s 10-K, filed March 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Cullinan Therapeutics, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cullinan Therapeutics, Inc.'s net margin?: Cullinan Therapeutics, Inc. (CGEM) reported net margin of -346.1% in Q4 2021.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.